Literature DB >> 10651161

Reperfusion arrhythmias in the murine heart: their characteristics and alteration after ischemic preconditioning.

J Sakamoto1, T Miura, A Tsuchida, T Fukuma, T Hasegawa, K Shimamoto.   

Abstract

In this study, we examined the features of reperfusion arrhythmias and the effect of preconditioning (PC) in the mouse for future application of genetically engineered mice to study mechanisms of this type of arrhythmia. Under pentobarbital anesthesia, reperfusion arrhythmias were induced by temporary occlusion of the left anterior descending coronary artery and reperfusion in BALB/c AJc1 mice. In the first protocol, the coronary artery was occluded for periods ranging from 2 to 15 min and then reperfused. In the second protocol, hearts were preconditioned with 2- or 3-min ischemia and 5-min reperfusion prior to the 5 min of coronary occlusion. An electrocardiogram was recorded throughout the experiment, and arrhythmias were diagnosed according to the Lambeth Convention criteria. The incidences of reperfusion-induced ventricular tachycardia (VT) in hearts that received 2, 3, 5, 10 and 15-min ischemia (n = 10 approximately 14) were 0, 9, 73, 55 and 30 %, respectively. Ventricular fibrillation (VF) was not observed upon reperfusion regardless of the ischemia duration. PC with 2-min ischemia and with 3-min ischemia (n = 10 for each PC) reduced the incidences of reperfusion VT after 5-min ischemia to 40% and 10%, respectively. However, in mice that developed reperfusion VT, the VT duration was similar to that in non-preconditioned controls, ranging from 1 to 16 s. These results suggest that the relationship between ischemia duration and incidence of VT upon subsequent reperfusion is "bell shaped" and that PC has anti-arrhythmic effects in the mouse, as it does in anesthetized rat hearts. However, there appear to be differences in the incidence of reperfusion-induced VF and the duration of reperfusion VT between these species. Thus, the present murine preparation appears to be a useful model for studying the mechanism of reperfusion VT and PC, though it does not share all of the features of reperfusion arrhythmias with the anesthetized rat preparation.

Entities:  

Mesh:

Year:  1999        PMID: 10651161     DOI: 10.1007/s003950050165

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  6 in total

1.  Expression of skeletal muscle sodium channel (Nav1.4) or connexin32 prevents reperfusion arrhythmias in murine heart.

Authors:  Evgeny P Anyukhovsky; Eugene A Sosunov; Yelena N Kryukova; Kevin Prestia; Nazira Ozgen; Mathilde Rivaud; Ira S Cohen; Richard B Robinson; Michael R Rosen
Journal:  Cardiovasc Res       Date:  2010-09-07       Impact factor: 10.787

Review 2.  Animal Models to Study Cardiac Arrhythmias.

Authors:  Daniel J Blackwell; Jeffrey Schmeckpeper; Bjorn C Knollmann
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

3.  Cardiac electrophysiology in mice: a matter of size.

Authors:  Sven Kaese; Sander Verheule
Journal:  Front Physiol       Date:  2012-09-05       Impact factor: 4.566

4.  Reperfusion-induced sustained ventricular tachycardia, leading to ventricular fibrillation, in chronically instrumented, intact, conscious mice.

Authors:  Heidi L Lujan; Stephen E DiCarlo
Journal:  Physiol Rep       Date:  2014-06-27

5.  Efficacious and safe orotracheal intubation for laboratory mice using slim torqueable guidewire-based technique: comparisons between a modified and a conventional method.

Authors:  Chieh-Shou Su; Hui-Chin Lai; Chih-Yen Wang; Wen-Lieng Lee; Kuo-Yang Wang; Ya-Ling Yang; Li-Chun Wang; Chia-Ning Liu; Tsun-Jui Liu
Journal:  BMC Anesthesiol       Date:  2016-01-18       Impact factor: 2.217

6.  Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death.

Authors:  Zhaoyang Hu; Feng Ju; Lei Du; Geoffrey W Abbott
Journal:  Cardiovasc Diabetol       Date:  2021-10-04       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.